Biotech funds top performance tables in risk-on November
Gold funds were worst performers
Pictet Biotech was the best-performing fund last month
Biotech funds topped the list of best-performing funds in November, while gold funds suffered during the month as investors rotated back into risk assets, according to Willis Owen.
Pictet Biotech was the best-performing fund last month, delivering a return of 13.65% based on FE Fundinfo data from 31 October to 30 November, followed by Polar Capital Biotechnology, which generated...
More on Funds
Back to Top
